L6: Safety & Dosing v6.2.9
System_SafePREPARE: 83.1% RRR · CPIC: 100%
PGx Dosing Guidance
100% CPIC CONCORDANCEDPYD
Intermediate Metabolizer
REDUCE 50%DPYD_TOX
DPYD
Intermediate Metabolizer
REDUCE 50%DPYD_VAR2
DPYD
Normal Metabolizer
FULL DOSEDPYD_WT
TPMT
Intermediate Metabolizer
REDUCE 30-70%TPMT_ADJ
UGT1A1
Poor Metabolizer
REDUCE 20%UGT1A1_PM
CYP2C19
Poor/Intermediate
AVOID CLOPIDOGRELCYP2C19_PM
CPIC Cases / Matched10/10 — 100%
IO Risk-Benefit Gate
NCB Gate ActiveFutile Toxicity Zone
Gate ResolutionDeterministic (15/15 Pass)
Cumulative Toxicity
Monitoring anthracycline and platinum dose accumulation with cross-resistance penalties.
Systemic Burden Index
42%NOMINAL
Risk-Benefit Formula
Net_Benefit =
(p_resp × Efficacy) -
(Risk_tox × Cost)
(p_resp × Efficacy) -
(Risk_tox × Cost)